Wähner, Cornelia
Hübner, Johannes
Meisel, Dörte
Schelling, Jörg
Zingel, Rebecca
Mihm, Sarah
Wölle, Regine
Reuschenbach, Miriam
Article History
Received: 28 September 2022
Accepted: 2 January 2023
First Online: 10 February 2023
Declarations
:
: CW, SM, MR are full-time employees of MSD Sharp and Dohme GmbH. RW was a full-time employee at the time of the study. RZ is a full-time employee of IQVIA and has acted as a subcontractor of MSD Sharp and Dohme GmbH in conducting this study. JS has received expense allowances from the following companies: MSD Sharp and Dohme GmbH, Sanofi-Pasteur, Pfizer, Seqirus, GSK. JH has received an expense allowance from MSD Sharp and Dohme GmbH. DM has received expense allowances from MSD Sharp & Dohme GmbH and Gedeon-Richter.
: Not applicable.